Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 9Triple Negative Breast Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Mouth Neoplasms 3Carcinoma, Intraductal, Noninfiltrating 2Breast Carcinoma In Situ 2Uterine Cervical Neoplasms 1Sentinel Lymph Node Biopsy (SLNB) 1Sarcoidosis, Pulmonary 1Sarcoidosis 1Rhabdomyosarcoma 1Recurrence 1Recurent Vulvar Carcinoma 1Rectal Neoplasms 1Pancreatic Neoplasms 1Melanoma 1Lymphoma 1Lymphatic Metastasis 1Lung Neoplasms 1HIV Infections 1FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1Eyelid Sebaceous Gland Carcinoma 1Cervical Adenocarcinoma 1Carcinoma, Ductal 1Anus Neoplasms 1

Interventions

pembrolizumab 7Nivolumab 7Specimen Handling 6Mitomycin 6Magnetic Resonance Spectroscopy 6Capecitabine 6Radiotherapy 5Fluorouracil 4Drug Therapy 4Biopsy 4Radiation 3Paclitaxel 3Ipilimumab 3Fluorodeoxyglucose F18 3Carboplatin 3dehydroftorafur 2atezolizumab 2aldesleukin 2Tomography, X-Ray Computed 2Sigmoidoscopy 2Radiotherapy, Intensity-Modulated 2Proctoscopy 2Mitozytrex 2Colonoscopy 2CTLA-4 Antigen 2Adoptive Transfer 2trastuzumab deruxtecan 1spartalizumab 1enzalutamide 1entinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anus Neoplasms × Sentinel Lymph Node Biopsy × 1 year × Clear all
NCT04929028 2026-05-13

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

National Cancer Institute (NCI)

Phase 2 Active not recruiting
40 enrolled
Gastrointestinal

Anus Neoplasms, Rectal Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡